Press Release: TREMFYA® (guselkumab) receives European Commission approval for adults with moderately to severely active ulcerative colitis, strengthening Johnson & Johnson’s leadership in inflammatory bowel disease
The firsta approved fully-human, dual-acting interleukin-23 (IL-23) inhibitor in moderately to severely active ulcerative colitis,1,2,3,4,5 guselkumab showed statistically higher rates of endoscopic normalisationb at Week 44 compared with placebo.2,6,7,8,9
THIS NEWS RELEASE IS NOT FOR DISSEMINATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA TO UNITED STATES NEWSWIRE SERVICES OR UNITED STATES PERSONS CALGARY, Alberta, July 29, 2025 (GLOBE NEWSWIRE) -- Questerre Energy Corporation (“Questerre” or the “Company”) (TSX,OSE:QEC) is pleased to announce that it has entered into a definitive agreement (the “Definitive Agreement”)…
BURNABY, British Columbia, July 28, 2025 (GLOBE NEWSWIRE) -- The United Steelworkers union (USW) District 3 and the USW Wood Council are calling on the federal government to take urgent action in response to the latest escalation in the softwood lumber trade dispute.
Performance Highlights GLEN COVE, N.Y., July 28, 2025 (GLOBE NEWSWIRE) -- Joseph Pistilli, Executive Chairman of the Board, of First Central Savings Bank (“FCSB”, “the Bank”) today reported continued performance achievements for the quarter ended June 30, 2025.
Los Angeles, CA, July 28, 2025 (GLOBE NEWSWIRE) -- For beginners looking to build muscle fast in 2025, achieving rapid growth involves more than just lifting weights. A proven combination of the right workout strategies, balanced nutrition, and effective supplements can accelerate muscle-building progress and enhance results.
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of CTO Realty Growth, Inc. (“CTO” or the “Company”) (NYSE: CTO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Tue, 15 Jul 2025 05:51:00 GMT Shareholders are encouraged to review the new supplement along with the original FAQ, which are both available on the Investor Relations page (https://ir.enovix.com) ...
Thu, 26 Jun 2025 21:00:00 GMT EATONTOWN, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ ...
